Provided by Tiger Trade Technology Pte. Ltd.

Novartis AG

137.48
-0.2200-0.16%
Pre-market: 138.060.5800+0.42%08:33 EDT
Volume:2.94M
Turnover:405.27M
Market Cap:262.31B
PE:20.78
High:139.45
Open:138.14
Low:137.30
Close:137.70
52wk High:170.46
52wk Low:121.57
Shares:1.91B
Float Shares:1.85B
Volume Ratio:0.65
T/O Rate:0.16%
Dividend:4.67
Dividend Rate:3.39%
EPS(TTM):6.61
EPS(LYR):7.15
ROE:30.35%
ROA:10.25%
PB:6.31
PE(LYR):19.23

Loading ...

Why the Dow is Being Dragged Down by a Swiss Company's Bad News

Dow Jones
·
Sep 08

Novartis AG Falls 13% in Pre-Market Trading, DM1 Drug Phase III Clinical Trial Fails to Meet Primary Endpoint

Market Focus
·
Sep 08

Novartis's Latest Trial Setback Sinks Stock

Dow Jones
·
Sep 08

Novartis Genetic Muscle Disorder Drug Fails Phase 3 Trial; Shares Drop Pre-Bell

MT Newswires Live
·
Sep 08

The Inflammation Bet Unravels: Novo And Novartis Both Stumble In Cardiovascular

Bellwether Stocks Movement
·
Sep 08

United Natural Foods, ABM Industries and 3 Stocks to Watch Heading Into Tuesday

Benzinga Earnings
·
Sep 08

Novartis's Latest Trial Failure is Second Pipeline Setback in a Row

Dow Jones
·
Sep 08

Movement Alert|Novartis AG Falls 4.16% Overnight, Phase III Heart Disease Drug Pelacarsen Fails Key Cardiovascular Trial

Market Focus
·
Sep 08

European Equities Remain Flat as Energy Gains Offset by Pharma Slump

Deep News
·
Sep 08

Novartis AG Falls Monday, Underperforms Market

Dow Jones
·
Sep 08

Citi says Novartis news increases likelihood Crispr prioritizes next-gen CTX321

TIPRANKS
·
Sep 07

Citi sees limited immediate downside for Ionis after pelacarsen failure

TIPRANKS
·
Sep 07

BofA sees low single-digit percentage downside for Novartis on pelacarsen miss

TIPRANKS
·
Sep 07

Novartis Shares Fall After Heart Drug Misses Target in Late-Stage Trial

Dow Jones
·
Sep 07

Novartis India to Acquire 'Minipress' Trademarks from Pfizer

Reuters
·
Sep 07

Second Clinical Trial Blow in a Week for Novartis as Heart Drug Disappoints, Dragging Down Amgen Shares

Stock News
·
Sep 07

Novartis Heart-Trial Failure Could be Mitigated by Investor Caution

Dow Jones
·
Sep 07

Novartis India - Deal Valued at 12.50 Bln Rupees

THOMSON REUTERS
·
Sep 07

Novartis Shares to Take Hit from Cholesterol Trial Failure

Dow Jones
·
Sep 07

Dow Jones Top Company Headlines at 9 PM ET: Amazon Cargo Plane Overshoots Runway in Miami, Killing Five People | Carmakers ...

Dow Jones
·
Sep 07